Home \ Expert Opinion \ Mexidol® in memory violation, anxiety, decreased mood, depression

Mexidol® in memory of memory, anxiety, decreased mood, depression

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
Features of therapy for memory disorders in the elderly
00:13
The causes of memory disorders
00:32
Symptoms of memory disorders
00:45
How to choose the necessary drug?

Mkhitaryan Helene Araikovna - Ph.D., Associate Professor of the Department of Diseases of Style FDPO RNEMU named after N.I. Pirogov MZ of the Russian Federation, head. Laboratory of Neuroheriatry of the RGNCC

Announcement:

Memory disorders are a common problem of elderly people. Often such disorders are associated with cerebrovascular damage to the brain and concomitant diseases. Patients not only lose the ability to remember information, but also experience anxiety, decreased mood and other symptoms. In this video, we will talk about the causes of memory impairment, as well as how to choose the right drug for therapy, why Mexidol® has a pronounced ability to improve memorization processes, how Mexidol® acts with depression.

Find out more in the video " Features of the conduct of elderly patients with chronic brain ischemia ."

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
Features of therapy for memory disorders in the elderly
00:13
The causes of memory disorders
00:32
Symptoms of memory disorders
00:45
How to choose the necessary drug?

Block of articles on this topic

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

Authors:
A.I. Fedin ¹ , V.V. Zakharov ² , M.M. Tanashian ³ , E.I. Chukanova ¹ , E.N. Majidova ⁴ , L.A. Shchepankevich ^5.6 , O.D. Ostroumova ⁷

The effectiveness and safety of the drug Mexol Forte 250 in the framework of consecutive therapy in patients with chronic brain ischemia

Author:
E.I. Chukanova, A.S. Chukanova

Department of Neurology, Neurosurgery and Medical Genetics of Faculty of Faculty of Faculty of FSBEI in "RNIMU named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The connection of cellular aging, cardiovascular diseases and anxiety disorders

Author:
A.P. Pereverzev

FSBOU DPO RANMO of the Ministry of Health of Russia

The study of the effectiveness and safety of the use of Mexidol and Mexidol Forte 250 in patients with chronic brain ischemia

Author:
V.A. Kutashov, O.V. Ulyanova

FSBEI in Voronezh State Medical University named after N.N. Burdenko »Ministry of Health of Russia, Voronezh, Russia

Features of pharmacotherapy of vascular cognitive impairment in elderly people

Author:
A.N. Bogolepova ^1, ²

¹ FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
² FSBI "Federal Center for Brain and Neurotechnology" of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com